The global animal health market size is anticipated to reach USD 67.56 billion by 2026 owing to the increasing number of animal health issues worldwide. Animals have always been of immense help to man either as companions or as livestock. With time, man starting adopting animals and keeping them as pets. Animals, alike humans, are susceptible to infections and diseases and require medical aid. As per a recently published report by Fortune Business insights™ titled, “Animal Health Market Size, Share and Global Trend By Product (Drugs, Vaccines, Feed, and Diagnostics), By Animal (Livestock Animals and Companion Animals), By End User (Veterinary Hospitals & Clinics, Animal Care & Rehabilitation Centers, Diagnostic Centers, and Others) and Geography Forecast till 2026” the market size was USD 41.50 billion in 2018 and is anticipated to rise at a CAGR of 6.3%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/animal-health-market-102371

Major Animal Health Companies in Market are as follows:

• Emergent BioSolutions, Inc.
• Boehringer Ingelheim International GmbH
• Novartis AG
• Virbac
• Intervet Inc.
• Bayer AG
• Zoetis
• Ceva
• Merck & Co., Inc.
• IDEXX Laboratories, Inc.
• CSL Limited
• Elanco

Objectives of the Report

The report on the veterinary healthcare market is based on qualitative and quantitative analysis of factors driving, repelling, and challenging the market. It also provides a well-presented segmentation of the market based on factors such as product, animal, end user, and region. Additionally, the report offers insights about key industry developments and recent innovations in the market with the list of market names and the blueprints chalked out by them to stay ahead of the market competition. Furthermore, the report lists the current animal healthcare market trends and opportunities and is available for sale on the company website.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/animal-health-market-102371

Major Growth Drivers:

Increasing Number of Pet Owners and Emphasis on Animal Health to Propel Growth

The increasing pet adoption is a major factor propelling animal health market growth. Besides this, analysts at Fortune Business Insights™ say, “the rising prevalence of diseases among animals, especially zoonotic diseases, is likely to promote the animal health market growth during the forecast period.” Zoonotic diseases can be transmitted from animals to humans; a few of which include bubonic plague, salmonellosis, anthrax, rabies, and West Nile virus. Besides this, the rise in the number of animal healthcare clinics worldwide will also drive the market.

Additionally, animals work as test subjects for various medication and drug tests. It is important to test drugs on animals attributable to the fact that research on most prolonged and genetic diseases affecting man cannot be approved for testing on human subjects. Animal studies are used for the development of new surgical techniques such as organ transplantations, new drug testing, and also for nutritional research. The fact that animals serve as research subjects for valuable research on long-lasting deteriorating diseases is further propelling the need to maintain the health of these animals.

Regional Analysis –

Presence of Advanced Teams for Research and Development Activities Will Aid Growth of the Market in North America

Geographically, the global animal health market is categorized into Europe, North America, Latin America, Asia Pacific, and the Middle East and Africa. These regions are further categorized into nations. Among these, North America held the largest veterinary healthcare market share and generated a revenue of USD 14.12 billion in 2018. This is attributable to the presence of numerous animal health centers and technologically advanced team for research and development of novel therapeutics. Besides this, the rise in the number of pet owners and their rising concern for maintaining the health of their pets will help in the expansion of the market.

The global contact lenses market size is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period. However, the market was worth USD 8.35 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775

Fortune Business Insights lists out some of the renowned companies operating in the contact lenses market. They are as follows:

• Contamac
• CooperVision
• HOYA Corporation
• Essilor
• Bausch & Lomb Incorporated
• Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
• ZEISS International
• Alcon Vision LLC
• Other key market players

Asia Pacific to Exhibit Rapid Growth Fueled by Rising Disposable Income

The contact lenses market can be geographically grouped into the Middle East & Africa, North America, Asia Pacific, Latin America, and Europe. Out of them, North America is set to dominate the market during the forecast period. It was valued at USD 2.75 billion in 2018. This growth is attributed to the rising usage of contact lenses amongst the masses as well as increasing prevalence of presbyopia. The Centers for Disease Control and Prevention (CDC) mentioned that in the U.S., around 45 million people use contact lenses.

Request a Sample Copy of the Global Contact Lenses Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contact-lenses-market-101775

Global Contact Lenses Market Segmentation

By Modality

• Reusable
• Disposable

By Design

• Toric
• Multifocal
• Spherical

By Distribution Channel

• Retail Stores
• Online Stores
• Ophthalmologists

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

What Does the Report Contain?

• In-depth information regarding all the possible segments, including modality, design, distribution channel, and region.
• Elaborate analysis of several insights, namely, contact lenses market trends, opportunities, growth drivers, and hindrances.
• Latest industry developments, such as new product launches, mergers, acquisitions, partnerships, and agreements.

Rising Prevalence of Ocular Disorders to Augment Market Growth

The World Health Organization (WHO) stated that approximately 1.7 million people are affected by presbyopia and around 153 million people reside with uncorrected refractive errors around the world. A rising prevalence of presbyopia worldwide is one of the main factors propeling the contact lenses market growth in the coming years. Also, many people are affected by ocular disorders, which in turn, is expected to boost growth of the market.

The global “Anti-Inflammatory Biologics Market Size” is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled “Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027” the market size stood at USD 64.84 billion in 2019.

The report covers:

• Global Anti-Inflammatory Biologics Market trends, with detailed analysis on consumer trends & manufacturer trends.
• Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
• Key areas of investments identifying market opportunities and challenges in forecast timeframe.
• Competitive analysis of the industry players along with the overview on strategic management.
• Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anti-inflammatory-biologics-market-102733

Leading Players operating in the Anti-Inflammatory Biologics Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• AbbVie Inc.
• Merck & Co., Inc.
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Pfizer Inc.
• Novartis AG
• UCB S.A.
• Eli Lilly and Company
• Amgen Inc.
• Biogen

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/anti-inflammatory-biologics-market-102733

 Regional Analysis:

Increasing Cases of Inflammatory Diseases to Boost Growth in North America

The market in North America stood at USD 28.63 billion in 2019. The growth of the region is attributed to rising government support for the introduction of biosimilars in the region. The potential pipeline candidates along with demand for anti-TNF drugs will aid healthy growth of the market in the region. The increasing prevalence of rheumatoid arthritis will spur demand for the market in North America. The approval of novel drugs will favor growth in Europe in the foreseeable future. For instance, in October 2018, Mylan announced the commercial launch of Hulio, a biosimilar of adalimumab. Asia Pacific is predicted to grow rapidly during the forecast period owing to the growing geriatric population. The increasing preference for biologics for inflammatory diseases will boost the market in Asia Pacific. The Middle East and Africa is likely to rise steadily in the forthcoming years owing to the improving healthcare infrastructure and rising disposable income.

 The global telerehabilitation market size is poised to rise remarkably in the coming years attributable to the technological advancements in the field of healthcare services in collaboration with information, technology, and communications. Telerehabilitation is a medical service for people preferring to stay at home and avail treatment and services. As per a recent report by Fortune Business Insights, titled, “Telerehabilitation Market Size, Share and Covid-19 Impact Analysis, By Type (Products, Services), By Application (Occupational Therapy, Physical Therapy, Chronic Diseases, and Others), By End-User (Healthcare Facilities and Homecare); and Regional Forecast, 2020-2027,” the market value stood at USD 3.32 billion in 2019 and is expected to rise at a CAGR of 13.4% to reach USD 9.13 billion by 2027. The forecast period is set between 2020 to 2027.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/telerehabilitation-market-103112

As per Fortune Business Insights™, some of the significant players in this market include:

• MIRA Rehab Limited (UK)
• (United States)
• Doctor On Demand, Inc. (United States)
• Care Innovations, LLC. (United States)

• American Well (United States)
• NeoRehab
• Hinge Health, Inc. (United States)
• Koninklijke Philips N.V. (Netherlands)
• Other players

We, at Fortune Business Insights, are offering special analytical reports on various markets impacted by the worldwide pandemic – COVID-19. As the world economy is shaken with most business at halt or generating meagre revenues, the governments are trying to find out measures to cope with this situation. These special reports will help investors to study the impact of coronavirus on various markets and accordingly take strategic decisions for better revenue generation in the coming years.

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/telerehabilitation-market-103112

The Report Answers the Following Questions:

• How fierce is the market competition?
• Which are the leading segments of the market?
• How will virtual consultation augment growth?
• What are the key industry developments and the current trends prevalent in the market?

Drivers & Restraints-

Increasing Geriatric Population Vulnerable to Various Diseases will Promote Growth

Telerehabilitation can address a wide variety of medical services through the means of telecommunication and technology. This is especially helpful in the case of patients residing in remote locations with mobility issues and for the aged population. The increasing geriatric population is a key factor promoting the telerehabilitation market growth. Additionally, a rise in the patient pool for chronic diseases is also set to aid in the expansion of the market in the coming years.

On the flip side, in several nations, telehealth services do not count as a part of the medical treatment and therefore, it becomes a tedious task to avail reimbursement for such services. The lack of or total absence of proper reimbursement policies for telehealth services are likely to cause hindrance to the market growth in the coming years. 

The global home infusion therapy market size is likely to USD 86.89 billion by the end of 2027 owing to the increasing adoption of home medical services worldwide. In a home infusion therapy setting, a patient receives all medical assistance at home including drugs and biologics via a subcutaneous or an intravenous administrative route. According to a recent report by Fortune Business Insights titled, “Home Infusion Therapy Market Size, Share & Industry Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027,” the value of this market was USD 27.25 billion in 2019 and is expected to grow at a CAGR of 2.2% between 2020 and 2027.

Fortune Business Insights™ lists out the names of market manufacturers. They are as follows:

• Optum, Inc.
• Infusystem
• Option Care Health Inc.
• Moog Inc.
• CareCentrix, Inc.
• Braun Melsungen AG
• Lincare Holdings Inc.
• Baxter
• Promptcare
• BriovaRx Infusion Services
• Other players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/home-infusion-therapy-market-102989

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: 

https://www.fortunebusinessinsights.com/home-infusion-therapy-market-102989

The Report Answers the Following Queries

• What is the nature of the market and how fierce is its competition?
• What are the key industry insights to the market?
• What strategies are adopted by players to gain momentum in the market?
• How is the COVID19 pandemic helping the market to grow?

Drivers & Restraints-

Lockdowns Amid COVID-19 Pandemic to Bode Well for the Market

The increasing prevalence of the geriatric population and their vulnerability towards chronic diseases such as cancer, diabetes, and cardiac issues among others stands as major home infusion therapy market devices. In addition to this, the increasing cases of hospital-acquired infections are also propelling people to opt for medical services at home. This, coupled with cost-efficient home treatment faster recovery at home than hospital are likely to bode well for the market.

On the flip side, most of the developing nations lack reimbursement structure and policy for home treatment which ultimately increases the out-of-pocket expenditure. This, coupled with a lack of proper medical assistance and limited sources in a home setting, may cause hindrance to the market. Nevertheless, the increasing number of innovations in the medical sector and the advent of devices such as portable infusion pumps, and others are likely to create lucrative growth opportunities for the market. Furthermore, the current pandemic of coronavirus that propelled people to stay at home is projected to promote the home infusion therapy market growth.

The global Nebulizer market size is projected to reach USD 1,778.8 million by 2027, exhibiting a CAGR of 8.1% during the forecast period. Increasing prevalence of respiratory disorders around the world will be the prime growth propeller for this market, shares Fortune Business Insights™ in its new report, titled “Nebulizer Market Size, Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027”.

List of Key Players Covered in this Market Report:

• Teleflex Medical, Inc.
• Trudell Medical International
• Briggs Healthcare
• PARI Respiratory Equipment, Inc.
• Omron Healthcare, Inc.
• Allied Healthcare Products, Inc.
• GF HEALTH PRODUCTS, INC.
• DeVilbiss Healthcare LLC
• Koninklijke Philips N.V.

The World Health Organization (WHO) states that respiratory diseases are the foremost cause of death and disability worldwide. According to its estimates, chronic obstructive pulmonary disorder (COPD) afflicts around 65 million and kills 3 million people every year. Similarly, pneumonia also kills millions of people annually and is the leading cause of mortality among children under 5 years of age. Furthermore, WHO data indicates that lung cancer is the deadliest cancer, killing 1.6 million people every year. Nebulizer play a key role in managing these chronic and potentially fatal lung disorders and as the incidence of these disorders grows, the demand for Nebulizer will continue to surge.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nebulizers-market-100707

The report states that the market value was at USD 909.7 million in 2019. Its other highlights include:

• Valuable insights into the key market drivers, trends, and restraints;
• Exhaustive analysis of the upcoming market opportunities;
• In-depth examination of the impact of the COVID-19 outbreak on the market; and
• Comprehensive study of the regional prospects and competitive dynamics influencing the market.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/nebulizers-market-100707

Market Opportunity

Rapid Transmission of the COVID-19 Infection to Create Immediate Growth Opportunities

The SARS-CoV-2 infection attacks the respiratory tract and lungs, causing shortness of breath, acute breathing problems, and pneumonia, along with a persistent fever and cough. People with preexisting lung disorders such as asthma are at high risk of contracting the COVID-19 infection. According to the Centers for Disease Control and Prevention (CDC), asthma patients are highly recommended to carry inhalers or portable Nebulizer with them as these devices can efficiently open the lungs and allow them to function normally. In this scenario, the uptake of inhalable drug delivery devices is likely to spike and favor the Nebulizer market growth. The only worry with these devices, as pointed out by the Asthma and Allergy Foundation of America, is their potential to transmit the infection among patients as well as healthcare workers, especially in healthcare facilities. If this issue is addressed, players can capitalize on the current pandemic and expand their presence in the market

The global insulin pump market is likely to gain impetus from the ever-increasing prevalence of diabetes reported worldwide. Coupled with this, the rising geriatric population and surging number of people affected by type 1 diabetes would drive the market growth. Fortune Business Insights™ provided this information in a recent report, titled, “Insulin Pump Market Size, Share & Industry Analysis, By Product Type (Pumps (Tethered Pumps, Patch Pumps, and Others), and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027.” The report further states that the insulin pump market size was USD 4.15 billion in 2019 and is projected to reach USD 8.50 billion by 2027, exhibiting a CAGR of 9.4% during the forecast period.

Fortune Business Insights™ lists out all the renowned organizations present in the insulin pumps market. They are as follows:

• Medtronic
• Insulet Corporation
• Hoffmann-La Roche Ltd.
• Tandem Diabetes Care, Inc.
• YPSOMED
• Others

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/insulin-pump-market-102735

This Report Answers the Following Questions:

• What are the insulin pumps and consumables market trends, opportunities, and challenges?
• Which segment is likely to lead the market in terms of share in the coming years?
• Which region would dominate the market by procuring the maximum revenue?
• Which significant strategies are being adopted by key companies to gain a competitive edge?

Drivers & Restraints-

Rising Technological Developments in Drug Delivery Systems to Propel Growth

New products are being launched by renowned companies nowadays owing to the advent of technological developments in the field of drug delivery systems. It is likely to drive the insulin pumps market growth in the near future. In addition to that, the manufacturers are persistently aiming to focus on upsurging the adoption and penetration of insulin pumps by creating awareness and reimbursement. It is mainly done in patients living with type 2 diabetes. However, many patients across the globe are dependent on other devices, such as insulin pens and injections, other than insulin pumps. It may hinder the growth of the market.

Request Sample: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/insulin-pump-market-102735

Competitive Landscape-

Novel Product Launches & Strategic Partnerships Pave the Way for Growth of Companies

Several enterprises operating in the market are persistently working towards widening their product portfolio and geographic presence. They are achieving their goals by focusing more on launching new devices featuring the latest technologies, as well as teaming up with the other companies. Below are a couple of the recent key industry developments:

• January 2020: Tandem Diabetes Care announced the launch of its new insulin pump named t:slim X2. It is equipped with Control-IQ technology to aid in surging time in range.
• June 2019: Medtronic and Tidepool partnered up to co-develop an interoperable automated insulin pump system.

The global wound care market size is projected to showcase significant progress and earn USD 24.55 billion by 2027. This is accountable to the increasing prevalence of chronic diseases such as diabetes, blood pressure, and the wounds that result from them, such as diabetic foot ulcers and pressure ulcers. Wound care is used for injuries that are unable to heal by themselves. If untreated, they may result in severe consequences, such as mobility issues, decreased elasticity of blood vessels, and others. A recent report by Fortune Business Insights offers an elaborative overview of the market. The report is titled, “Wound Care Market Size, Share & Covid-19 Impact Analysis, By Type (Advanced Wound Dressing, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives, and Others), By Application (Chronic Wounds, and Acute Wounds), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2020-2027.” According to this report, the market value stood at USD 15.68 billion in 2019 and is likely to exhibit a CAGR of 6.0% between 2020 to 2027.

As per a report by Fortune Business Insights™, some of the significant players in the market are as follows:

• Johnson & Johnson Services, Inc.
• Smith & Nephew
• Coloplast Corp
• Cardinal Health
• ConvaTec Inc.
• Medtronic
• 3M
• BSN Medical (Essity)
• PAUL HARTMANN AG
• Other players

The worldwide pandemic of COVID-19 has shaken the world economy. Most businesses are at a halt, import-export is not possible, and the entire world is hoping to come out of this situation. With government support and necessary measures, we soon hope to overcome this situation and step into a better tomorrow. We, at Fortune Business Insights, are offering special reports on various markets impacted by the coronavirus pandemic and its future objectives. These reports will help investors study the market thoroughly and accordingly chalk out business strategies for generating future revenues.

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit: 

https://www.fortunebusinessinsights.com/wound-care-market-103268

The report is based on the following questions:

• What is the nature of the market?
• Which is the leading segment?
• Who is the leading player of the wound care market?
• How is the prevalence of diabetes aiding in the expansion of the market?
• What are the key developments of the market?

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/wound-care-market-103268

Drivers & Restraints-

Increasing Popularity of Bioactive Therapy to Add Impetus to Market

The rising prevalence of acute and chronic diseases such as diabetic foot ulcers, pressure ulcers, and others are some of the key factors promoting this market growth. This, coupled with the advent and adoption of technologically advanced wound care products, will also add impetus to the market. Additionally, continuous research and development, as well as increasing investments in the launch of advanced wound care products are likely to bolster growth in the coming years.

On the contrary, high treatment costs and the presence of limited or no reimbursement policies, especially in the underdeveloped nations, may challenge the growth of the market. Nevertheless, the advent of bioactive therapy for treating chronic wounds is expected to create a lucrative growth opportunity for the market in the coming years.

 Segment:

Advanced Wound Dressing Segment to earn Largest Share Owing to Better Product Offering

Based on segmentation by type, the advanced wound dressing segment earned 42.6% wound care market share in 2019 and emerged dominant. This is owing to the presence of a diverse product portfolio.

The global sleep apnea treatment devices market size is set to touch USD 8.97 billion by 2026, exhibiting a CAGR of 8.2% during the forecast period. Steadily climbing demand for sleep apnea devices, stemming from a consistent spread in the prevalence of sleep apnea, will be a major growth driver for this market, shares Fortune Business Insights™ in its new report, titled “Sleep Apnea Treatment Devices Market Size, Share & Industry Analysis, By Device Type (Positive Airway Pressure (PAP) Devices, Oral Appliances, Masks & Accessories, and Others), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/sleep-apnea-treatment-devices-market-102694

List of Players Covered in the Report:

• Braebon Medical Corporation
• Glidewell
• Oventus
• Fisher & Paykel Healthcare Limited
• ResMed
• DeVilbiss Healthcare
• BMC Medical Co., Ltd.
• SomnoMed
• Koninklijke Philips N.V.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sleep-apnea-treatment-devices-market-102694

A study published in the medical journal Lancet in 2019 found that nearly 1 billion people worldwide suffer from Obstructive Sleep Apnea (OSA). Regionally, too, the statistics conform to the global trends. For instance, the European Respiratory Society estimates that 13% to 32% of the geriatric population in Europe suffer from sleep apnea. As a result, the demand for sleep apnea treatment is escalating and driving the sleep apnea treatment devices market trends. Furthermore, the incidence of OSA is spiking owing to the rising prevalence of obesity, the most common cause for interrupted sleep, which according to the World Health Organization, presently affects close to 650 million adults worldwide.

According to the report, the value of the market stood at USD 4.82 billion in 2018. The report further contains:

• Thorough analysis of the factors and trends driving and restraining the market;
• Comprehensive research into the regional and competitive dynamics of the market;
• Detailed segmentation of the market and in-depth evaluation of the individual market segments; and
• Precise computation of market figures and values.

Market Restraint

Discomfort Caused by CPAP Masks to Stall Market Growth

Continuous Positive Airway Pressure (CPAP) is a highly recommended therapy for sleep apnea patients. It involves a machine that uses mild air pressure to keep airways open, helping an apneic person get sound sleep. However, despite its popularity, CPAP entails certain disadvantages that are likely to negatively affect the sleep apnea treatment devices market growth. For example, CPAP machines are infamous for causing discomfort as patients find it difficult to sleep in specific positions so as to not to displace the mask on their face. Moreover, the mask can also lead to a runny nose or cause nasal congestion. The biggest hindrance for this market, however, is the high cost associated with CPAP devices, especially in emerging economies. The challenge is humungous as insurance coverage in these countries is poor and limited and reimbursement policies are unfavorable for patients, hampering the adoption of this treatment method.

The global non-Hodgkin lymphoma treatment market size is projected to reach USD 12.57 billion by the end of 2026. The increasing number of regulatory approvals will aid the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Non-Hodgkin Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (B-cell Lymphoma, and T-cell Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), and Regional Forecast, 2019-2026,” the market was worth USD 6.60 billion in 2018 and will exhibit a CAGR of 8.4% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/non-hodgkin-lymphoma-treatment-market-102642

Some of the leading companies that are operating in the market include:

• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Bayer AG
• Novartis AG
• Kite Pharma, Inc. / Gilead Sciences, Inc.
• Spectrum Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd.
• Bristol Myers Squibb Company
• Janssen Pharmaceuticals, Inc.
• Genentech, Inc. (F. Hoffmann-La Roche Ltd)
• CELGENE CORPORATION (Bristol Myers Squibb Company)
• Merck & Co., Inc.
• Kyowa Kirin Co., Ltd.
• AbbVie Inc.
• Sanofi
• Others

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/non-hodgkin-lymphoma-treatment-market-102642

Non-Hodgkin lymphoma is a type of cancer that has an effect on the white blood cells of the human body. The disease reduces the immunity of the human body. The severity of the disease has led to a huge emphasis on the R&D of treatment methods. As a result, high investments are being made towards developing efficient treatment methods. The high prevalence of the disease across the world has also caught the eye of investors. There are numerous clinical trials associated with the treatment of the diseases. The focus on therapeutics has risen dramatically in recent years. The increasing prevalence of the disease has compelled companies to look into the non-Hodgkin lymphoma therapeutics and this in turn will contribute to the growth of the market in the coming years.

Increasing Number of Regulatory Approvals Will Aid Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, the increasing number of regulatory approvals has made a huge impact on the growth of the overall market. In October 2017, AstraZeneca announced that it has received approval from the US Food and Drug Administration (FDA) for its latest treatment option for non-Hodgkin lymphoma. The company announced that ‘Calquence’ was cleared for use in treatment of patients suffering from the disease. The company looks to build on its previous steps taken to establish a stronghold in the market. This product will not just help the company grow, but will also have a positive impact on the growth of the market in the forthcoming years.